Combivent Respimat
Payments companies reported to CMS as associated with Combivent Respimat. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Combivent Respimat, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Combivent Respimat
These are the largest totals companies reported as associated with Combivent Respimat. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Thomas Frederickson | Omaha, NE | Internal Medicine | $94.04 |
| Todd Viccione | East Greenwich, RI | Internal Medicine | $59.33 |
| Charles Shapiro | Bayside, NY | Allergy | $43.44 |
| Sola Kim | N Charleston, SC | Pulmonary Disease | $41.30 |
| Alan Brau | Bethlehem, PA | Pulmonary Disease | $41.07 |
| Robert Mittman | Bayside, NY | Allergy & Immunology | $40.48 |
| Hannah Graham | Pinehurst, NC | Physician Assistant | $38.71 |
| Gleybis Sanchez | Rockingham, NC | Internal Medicine | $38.71 |
| Morgan Rubenstein | North Charleston, SC | Acute Care (Nurse Practitioner) | $36.49 |
| John Rucker | North Charleston, SC | Pulmonary Disease | $36.49 |
Prescribed Combivent Respimat?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.